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We recently found a previously unidentified cDNA in chicken hypothalamus which
encodes the precursor for neurosecretory protein GL (NPGL). A previous study showed
that intracerebroventricular (i.c.v.) infusion of NPGL caused body mass gain in chicks.
However, it was not clear which part(s) of the body gained mass. In the present study,
we investigated which tissues increased in mass after chronic i.c.v. infusion of NPGL
in chicks. We found that NPGL increased the masses of the liver, abdominal fat, and
subcutaneous fat, while NPGL did not affect the masses of muscles, including pectoralis
major, pectoralis minor, and biceps femoris. Oil RedO staining revealed that fat deposition
had occurred in the liver. In addition, the size of the lipid droplets in the abdominal fat
increased. Furthermore, we found an upregulation of lipogenesis and downregulation of
lipolysis in the abdominal fat, but not in the liver. These results indicate that NPGL is
involved in fat storage in chicks.
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INTRODUCTION
The processes of animal development and growth are regulated by several hormones, genetics,
nutrition, and the environment (1). Among these factors, growth hormone (GH), produced by
the pituitary gland, and insulin-like growth factor-1 (IGF-1), made by the liver, play important
roles in the growth of peripheral tissues, including bone, liver, muscle, and adipose tissue (1, 2). In
addition, increases in the masses of peripheral tissues are also influenced by energy states, such as
starvation and satiation. For energy homeostasis, bioactive substances, including neuropeptide Y
(NPY), glucocorticoids, and leptin from the hypothalamus, adrenal gland, and adipose tissue, can
also influence body mass growth in mammals (3–5). These neuropeptides, or circulating steroids
and peptide hormones are secreted in response to physiological conditions, and the signals are
finally integrated in the hypothalamus to regulate feeding behavior. Owing to the complexity of
feeding regulation and growth, the exact mechanism(s) regulating these physiological processes
remains to be elucidated.
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The efficiency of nutrient utilization and growth rate in
domestic animals is very important for the farming/food
industry. Particularly significant progress has been made over
the last several decades in poultry production following
genetic selection (6). Orexigenic and anorexigenic factors act
differently in birds as compared to mammals. In mammals, NPY,
agouti-related protein (AgRP), melanin-concentrating hormone
(MCH), orexin, and ghrelin stimulate food intake (7, 8). In
contrast to mammals, MCH and orexin do not affect food intake
of chicks, and ghrelin inhibits feeding behavior (9). In addition
to the differential effects in birds and mammals, it is likely that
other undiscovered factors take part in the regulation of feeding
and growth.
In a preceding study, we aimed to find unknown regulatory
substance(s) in the chicken hypothalamus that affect neuronal
control of feeding behavior and/or growth. Food intake, energy
consumption, and increase in body mass are inextricably linked
to animal growth. We recently deduced a cDNA from chicken
hypothalamus that encodes the unidentified precursor to a
small neurosecretory protein (10). The deduced pre-pro-protein
contains a signal peptide sequence, a mature secretory protein
sequence of 80 amino acid residues, a glycine amidation signal,
and a cleavage signal consisting of dibasic amino acids (Lys-
Arg) (10). The predicted C-terminal amino acid sequences were
Gly-Leu-NH2, so we termed the protein neurosecretory protein
GL (NPGL) (10). In situ hybridization revealed that the NPGL
mRNA was expressed in the infundibular nucleus (IN) and the
medial mammillary nucleus (MM) of the hypothalamus (10).
The IN and MM in chicks are known to correspond to the
mammalian arcuate nucleus (Arc) and the tuberomammillary
nucleus (TMN), respectively; both nuclei are recognized to be
involved in regulation of food intake in mammals. In addition,
we found that the expression levels ofNPGLmRNAwere elevated
during the post-hatch period (10). Furthermore, we reported
that subcutaneous administration of NPGL for 4 days increased
body mass gain independently of feeding behavior in chicks (10).
Chronic intracerebroventricular (i.c.v.) infusion of NPGL for 2
weeks stimulated intake of food and water, with an associated rise
in body mass (11). These data indicate that NPGL may influence
growth processes of chicks. However, the specific body tissue(s)
that are actually impacted by NPGL administration have not been
elucidated. In the present study, we addressed this gap in our
knowledge of NPGL action.
MATERIALS AND METHODS
Animals
Male layer chicks (Gallus domesticus, 1 day old, n = 8 in each
group) were obtained from a commercial hatchery (Nihon Layer,
Gifu, Japan) and kept in a windowless room at 28◦C on a
light/dark cycle: 20 h light (4:00–24:00) and 4 h dark (0:00–4:00)
according to our previous report (11). The chicks had access
to food and water ad libitum. Chicks were raised in a group
and then separated into individual cages from 4 days of age
in order to measure individual food intake. The experimental
protocols were in accordance with the Guide for the Care and
Use of Laboratory Animals prepared by Hiroshima University
(Higashi-Hiroshima, Japan).
Production of Chicken NPGL
Chicken NPGL was synthesized with
Fluorenylmethyloxycarbonyl (Fmoc) chemistry using a peptide
synthesizer (Syro Wave; Biotage, Uppsala, Sweden) according
to our previous method (12). The protein was cleaved from the
resin with reagent K (trifluoloacetic acid: TFA 82.5%, phenol 5%,
thioanisol 5%, H2O 5%, and 1,2-ethanedithiol 2.5%) for 3 h. The
crude protein was purified by reverse-phase high-performance
liquid chromatography (HPLC) using a C18 column (YMC-Pack
ProC18, 10 × 150mm; YMC, Kyoto, Japan) at a flow rate
of 1.0 ml/min for 40min with a linear gradient of 40–60%
acetonitrile containing 0.1% TFA. The solvent was evaporated
and lyophilized. The protein was dissolved in dimethyl sulfoxide
(DMSO) and then diluted to a final concentration of 0.5mM
glutathione disulfide, 5mM glutathione, 50% acetonitrile,
1mM EDTA, 10% DMSO, 0.4M Tris-HCl (pH 8.5). The
solvent was rotated for 2 days at room temperature to allow
for an intramolecular disulfide bond to form, purified by
HPLC and then lyophilized. The purity of the protein was>95%.
Lyophilized NPGL was weighed using an analytical and precision
balance (AP125WD; Shimadzu, Kyoto, Japan).
i.c.v. Infusion of NPGL for 2 Weeks
NPGL was dissolved in absolute propylene glycol and adjusted
to 30% propylene glycol as a vehicle solution. Eight day old
chicks were i.c.v. infused with 0 (vehicle) or 15 nmol/day NPGL
via an infusion cannula (model 328OP; Plastics One, Roanoke,
VA) and an Alzet mini-osmotic pump (model 2002, delivery rate
0.5 µl/h; DURECT Corporation, Cupertino, CA). The dose was
determined on the basis of previous studies (11, 13). The infusion
cannula tip was implanted into the lateral ventricle: 2.0mm
rostral to lambda, 1.0mm lateral to midline, and 5.5mm ventral
to the skull surface. Osmotic mini-pumps containing vehicle or
NPGL were implanted subcutaneously in the neck according to
our previous method (11).
Body mass and food intake were measured daily (between
9:00–10:00) throughout the experiment. After 2 weeks of i.c.v.
infusion of NPGL, chicks were killed by decapitation and
masses of liver, abdominal fat, subcutaneous fat, pectoralis major
muscle, pectoralis minor muscle, and biceps femoris muscle
were measured.
Histological Analysis
For Oil Red O staining to detect fat accumulation, the livers
from 5 animals of each group were fixed in 4% paraformaldehyde
and sliced into 10µm sections. These were air-dried, rinsed with
60% isopropanol, stained with Oil Red O solution for 15min
at 37◦C, and rinsed with 60% isopropanol. The nucleus was
counterstained with hematoxylin for 5min, and the sections
were washed in tap water. The slides were mounted in aqueous
mounting medium for microscopic examination.
For hematoxylin and eosin staining, fixed abdominal fat
was embedded in paraffin and cut into 7µm sections with a
microtome. The sections were then delipidated with acetone.
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The nucleus and cytoplasm were stained with hematoxylin and
eosin (5min for each stain), and the sections were washed in
tap water. After serial dehydration with alcohol and clearing
with xylene, the sections were mounted on slides for microscopic
examination using an Eclipse E600 conventional microscope
(Nikon, Tokyo, Japan).
Real-Time RT-PCR
The procedures were carried out in a similar manner to our
previous report (11). At the end of the NPGL infusions, chicks
were killed by decapitation between 13:00–15:00. The liver and
abdominal fat were dissected out and snap-frozen in liquid
nitrogen. RNA was extracted using TRIzol reagent for liver
(Life Technologies, Carlsbad, CA) or QIAzol lysis reagent for
abdominal fat (QIAGEN, Venlo, Netherlands) following the
manufacturer’s instructions. First-strand cDNA was synthesized
from total RNA (1 µg) using a ReverTra Ace kit (TOYOBO,
Osaka, Japan).
PCR amplifications were conducted using THUNDERBIRD
SYBR qPCR Mix (TOYOBO) and the following procedure:
95◦C for 20 s, followed by 40 cycles at 95◦C for 3 s, and at
60◦C for 30 s using a real-time thermal cycler (CFX Connect;
BioRad, Hercules, CA). Amplifications of lipogenic and lipolytic
enzymes and related factors were performed with the primer sets
listed in Table 1. We chose acetyl-CoA carboxylase (ACC), fatty
acid synthase (FAS), stearoyl-CoA desaturase 1 (SCD1), malic
enzyme (ME) as lipogenic enzymes, peroxisome proliferator-
activated receptor γ (PPARγ) as cell differentiation marker,
fatty acid transporter 1 (FATP1) as fatty acid uptake, and
PPARα, carnitine palmitoyltransferase 1a (CPT1a), lipoprotein
lipase (LPL), adipose triglyceride lipase (ATGL), and comparative
gene identification-58 (CGI-58) as lipolytic enzymes and
related factors.
The relative quantification for each expression was
determined by the 2−11Ct method (14) using β-actin (ACTB) as
the internal control.
Statistical Analysis
Data were analyzed with Student’s t-test for tissue mass and
mRNA expression or one-way repeated measures analysis of
variance (ANOVA) followed by Bonferroni’s test for body mass
gain and cumulative food intake. The significance level was set at
P < 0.05. All results are expressed as the mean± SEM.
FIGURE 1 | Effect of chronic i.c.v. infusion of NPGL on body mass gain and
food intake. The results were obtained by the infusion of the vehicle (control;
CTL) and NPGL. The change in the body mass gain after surgery (A). The
cumulative food intake (B). Data are expressed as the mean ± SEM (n = 8).
Data were analyzed with a one-way repeated measures analysis of variance
(ANOVA), followed by Bonferroni’s test. An asterisk indicates a statistically
significant difference (*P < 0.05, **P < 0.01, ***P < 0.001).
TABLE 1 | Sequences of oligonucleotide primers for real-time PCR.
Gene Forward primer Reverse primer Accession no.
ACC AATGGCAGCTTTGGAGGTGT TCTGTTTGGGTGGGAGGTG NM_205505.1
FAS CCAACGATTACCCGTCTCAA CAGGCTCTGTATGCTGTCCAA NM_205155.2
SCD1 AGTGGTGTTGCTGTGCTTCA CTAAGGTGTAGCGCAGGATG NM_204890.1
ME AGTGCCTACCTGTGATGTTG GGCTTGACCTCTGATTCTCT NM_204303.1
PPARγ TCAAGCATTTCTTCACCACACT ATTGCACTTTGGCAATCCTGG NM_001001460.1
FATP1 TACAATGTGCTCCAGAAGGG GTCTGGTTGAGGATGTGACTC NM_001039602.2
PPARα TGCTGTGGAGATCGTCCTGGT AGAGGAAGATATCGTCAGGATGG NM_001001464.1
CPT1a TGATCTGAAGAAGAACCCTGAGAT TCCAAAGCGATGAGAATCCG NM_001012898.1
LPL CAGTGCAACTTCAACCATACCA AACCAGCCAGTCCACAACAA NM_205282.1
ATGL CACTGCCATGATGGTCCCCTA CCACAAGGAGATGCTGAAGAA NM_001113291.1
CGI-58 ACCGTGGTTTATGGAGCACG GAAACAGTGTGCAAACAGAGCC NM_001278145.1
ACTB CCAGAGTCCATCACAATACC AGCCAACAGAGAGAAGATGA NM_205518.1
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RESULTS
Effect of i.c.v. Infusion of NPGL on Body
Mass Gain, Food Intake, and
Body Composition
NPGL infusion significantly promoted body mass gain
(Figure 1A), and NPGL also increased cumulative food
intake (Figure 1B). Furthermore, NPGL increased the mass of
the liver, abdominal fat, and subcutaneous fat (Figure 2A), while
no change was observed in the muscle mass of the pectoralis
major muscle, pectoralis minor muscle, and biceps femoris
muscle (Figure 2B).
Effect of i.c.v. Infusion of NPGL on Lipid
Deposition in the Liver and Abdominal Fat
Lipid droplets were observed in the liver after chronic i.c.v.
infusion of NPGL, increasing its mass (Figure 3). Moreover,
abdominal fat accumulated around the gizzard in the NPGL-
infused chicks (Figure 4, left in lower panel). The lipid droplets
in the abdominal fat of the chicks were substantially larger after
chronic NPGL infusion than those in the controls (Figure 4, right
in lower panel).
FIGURE 2 | Effect of chronic i.c.v. infusion of NPGL on body composition. The
results were obtained by the infusion of the vehicle (CTL) and NPGL for 2
weeks. The masses of the liver, abdominal fat, and subcutaneous fat (A), and
pectoralis major muscle, pectoralis minor muscle, and biceps femoris muscle
(B) were measured at the end of experiment. Data are expressed as the mean
± SEM (n = 8). Data were analyzed by Student’s t-test. Asterisks indicate
statistically significant differences (*P < 0.05, **P < 0.01, ***P < 0.001).
Effect of i.c.v. Infusion of NPGL on the
mRNA Expression of Lipogenic and
Lipolytic Factors in the Liver and
Abdominal Fat
To investigate the gene expression of lipogenic and lipolytic
factors in the liver and abdominal fat, we analyzed the mRNA
levels of ACC, FAS, SCD1, ME, PPARγ , FATP1, PPARα, CPT1a,
LPL, ATGL, and CGI-58 after chronic i.c.v. infusion of NPGL.
NPGL decreased the mRNA expression of PPARα in the liver
(Figure 5) and increased the expression of FAS, SCD1, and
PPARγ in the abdominal fat; whereas, NPGL decreased the
CPT1amRNA (Figure 6).
DISCUSSION
The precursor gene for NPGL was identified in the chicken
hypothalamus through a cDNA subtractive screen designed to
identify novel neuronal substance(s) in the avian brain (10).
After sequencing 596 clones from hypothalamic cDNA, we found
an unidentified cDNA that encodes an unknown protein. The
deduced precursor protein consisted of 182 amino acid residues,
containing a putative secretory protein of 80 amino acid residues,
and which had Gly-Leu-NH2 at its C-terminus. Therefore,
FIGURE 3 | Effect of chronic i.c.v. infusion of NPGL on lipid deposition in the
liver. The results were obtained 2 weeks after infusion of the vehicle (CTL) and
NPGL. Representative photomicrographs of the sections stained by Oil Red O
staining (scale bar = 100µm).
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FIGURE 4 | Effect of chronic i.c.v. infusion of NPGL on the lipid droplets in the abdominal fat. The results were obtained 2 weeks after infusion of the vehicle (CTL) and
NPGL. Exterior photographs of the abdominal fat around the gizzard (left panel, scale bar = 1 cm), and representative photographs of the sections stained by
hematoxylin and eosin staining (right panel, scale bar = 100µm).
FIGURE 5 | Effect of chronic i.c.v. infusion of NPGL on the mRNA expression of lipogenic and lipolytic factors [acetyl-CoA carboxylase (ACC), fatty acid synthase
(FAS), stearoyl-CoA desaturase 1 (SCD1), malic enzyme (ME), peroxisome proliferator-activated receptor γ (PPARγ ), fatty acid transporter 1 (FATP1), peroxisome
proliferator-activated receptor α (PPARα), carnitine palmitoyltransferase 1a (CPT1a), lipoprotein lipase (LPL), adipose triglyceride lipase (ATGL), and comparative gene
identification-58 (CGI-58)] in the liver. The results were obtained 2 weeks after infusion of the vehicle (CTL) and NPGL. Data are expressed as the mean ± SEM (n = 8).
Data were analyzed by Student’s t-test. An asterisk indicates a statistically significant difference (*P < 0.05).
the protein was termed neurosecretory protein GL (NPGL)
(10). As NPGL contains two Cys residues, the presence of an
intramolecular disulfide bond bridge is likely (10). Subcutaneous
administration of NPGL can cause an increase in body mass
of chicks without affecting feeding behavior (10). However, the
exact body components that are affected by NPGL had not
been studied. The aim of this study was determination of the
body component(s) that increased after NPGL infusion. We
measured the masses of various tissues, including the liver, fat,
and muscles after 2 weeks of i.c.v. NPGL infusion. The results
showed that NPGL increased the mass of the liver, abdominal fat,
and subcutaneous fat (Figure 2A), while no change was observed
in the muscle masses of pectoralis major, pectoralis minor,
and biceps femoris (Figure 2B). As we speculated that NPGL
stimulates fat accumulation in the liver and adipose tissue, this
phenomenon was confirmed using a morphological analysis. The
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FIGURE 6 | Effect of chronic i.c.v. infusion of NPGL on the mRNA expression of lipogenic and lipolytic factors [acetyl-CoA carboxylase (ACC), fatty acid synthase
(FAS), stearoyl-CoA desaturase 1 (SCD1), malic enzyme (ME), peroxisome proliferator-activated receptor γ (PPARγ ), fatty acid transporter 1 (FATP1), peroxisome
proliferator-activated receptor α (PPARα), carnitine palmitoyltransferase 1a (CPT1a), lipoprotein lipase (LPL), adipose triglyceride lipase (ATGL), and comparative gene
identification-58 (CGI-58)] in abdominal fat. The results were obtained 2 weeks after infusion of the vehicle (CTL) and NPGL. Data are expressed as the mean ± SEM
(n = 8). Data were analyzed by Student’s t-test. Asterisks indicate statistically significant differences (*P < 0.05, **P < 0.01, ***P < 0.001).
results revealed lipid deposition in the liver and the enlargement
of lipid droplets in the abdominal fat (Figures 3, 4).
In the experiments to survey the gene expression related to
lipogenic and lipolytic factors, we found a decrease in the PPARα
mRNA in the liver, increases in FAS, SCD1, and PPARγ , and a
reduction of CPT1a in the abdominal fat. It is known that target
genes of PPARα participate in fatty acid β-oxidation in the liver
(15, 16). FAS and SCD1 are lipogenic enzymes, and CPT1a is
lipolytic enzyme (17). It has been reported that PPARγ plays
important roles in the process of adipogenic differentiation (18).
Taken together with these findings, the present study suggests
that NPGL inhibits fatty acid oxidation in the liver and induces
de novo lipogenesis in adipose tissue. It has been demonstrated
previously in birds that de novo fatty acid synthesis takes place
predominantly in the liver (19). The present data indicate the
novel possibility of de novo lipogenesis in the adipose tissue
of birds.
In mammals, de novo lipogenesis is the process of
transforming non-lipid precursors into fatty acids and
triglycerides for energy storage (20). Although de novo
lipogenesis in adipose tissue is important for the maintenance
of metabolic homeostasis, de novo lipogenesis in non-adipose
tissues, such as the liver and muscle, results in ectopic lipid
deposition, lipotoxicity, and metabolic stress disorder (21, 22).
Lipogenesis and lipolysis in adipose tissue are controlled by
the hypothalamus via the sympathetic nervous system (23, 24).
Therefore, it is likely that NPGL takes part in the sympathetic
control of fat accumulation in chicks, although there may be
other pathways that mediate its actions. Future studies are
necessary to classify the target regions and neuronal networks
regarding the NPGL neurons to elucidate the exact mechanism
of de novo lipogenesis in birds.
The present study also showed that i.c.v. infusion of NPGL
stimulated food intake. As mentioned above, subcutaneous
infusion of NPGL did not affect the feeding behavior of chicks
(10). The results from the present study suggest that NPGL
may act on the brain to stimulate feeding behavior, although we
have found that NPGL did not change the mRNA expression
of various hypothalamic ingestion-related neuropeptides, i.e.,
NPY, AgRP, proopiomelanocortin (POMC; precursor of α-
melanocyte-stimulating hormone), glucagon-like peptide (GLP-
1), and cholecystokinin (CCK) (11). Future studies are needed to
elucidate the target neurons of NPGL that alter feeding behavior.
After the identification of the NPGL precursor gene in the
chicken hypothalamus, we searched for related genes in the
genome database (TBLASTN) using the amino acid sequence of
the NPGL precursor. We found an orthologous gene in humans
and rats (10). In addition, the NPGL precursor gene is conserved
in mouse, turtle, frog, and fish (25). In fact, we cloned the
cDNA encoding NPGL in the mouse and rat hypothalamus
and found that the mature NPGL amino acid sequence was
85% similar between chicken and rodent (26, 27). In mice, we
demonstrated that acute i.c.v. injection of NPGL increased food
intake from 2 to 10 h after administration (26). Although we also
performed acute injection of NPGL in chicks in our preliminary
experiments, we did not observe a significant effect on feeding
behavior. The data suggest that the mechanisms of action of
NPGL on food intake differ between chicks andmice. The present
data show that chronic infusion of NPGL stimulated feeding
behavior as mentioned above. We need to elucidate the reasons
for differential effects of acute and chronic administration of
NPGL on food intake in future studies.
Recently, we also investigated the biological actions of NPGL
in rats by overexpressing the NPGL precursor gene in the
hypothalamus and chronic i.c.v. infusion of NPGL peptide,
similar to the present study. The results showed that NPGL
induced a significant rise in the mass of adipose tissue and
the magnitude of adipocytes in rats (27). Next, we investigated
the mRNA expression of lipogenic and lipolytic enzymes in
the adipose tissue and liver of rats and found that the mRNA
expression levels of the lipogenic enzymes in the adipose tissue
significantly increased after NPGL overexpression and i.c.v.
infusion of NPGL, but no differences were detected in the
liver (27). Thus, NPGL-induced de novo lipogenesis does not
occur in the liver, but is restricted to adipose tissue. To our
knowledge, the previous study in rats was the first report of
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an endogenous neuronal substance that can regulate peripheral
de novo lipogenesis in animals (27). In the present study, we
also found that peripheral de novo lipogenesis was induced by
chronic i.c.v. infusion of NPGL in chicks. These results suggest
that NPGL-induced de novo lipogenesis in adipose tissue is a
conserved property in birds and rodents.
In conclusion, a chronic i.c.v. administration of NPGL
stimulated food intake, increased the masses of the liver and
adipose tissue, and finally, caused an increase in body mass
gain in developing chicks. Thus, NPGL is a positive regulator of
feeding and growth post-hatch. This is the first report describing
the upregulation of de novo lipogenesis from chronic i.c.v.
infusion of NPGL in birds. The cognate receptor for NPGL has
yet to be characterized in any animal, but this will be necessary
in order to elucidate the precise roles of NPGL action in the
brain. Regulation of feeding behavior and fat storage are vital
for survival and for the transition into specific life-history stages,
such as pregnancy, puberty, aging, migration, and hibernation.
Future comparative analyses using other animal models will help
elucidate the unity and diversity of the physiological functions
of NPGL.
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